Respiratory Diseases Drugs Global Market Report 2018

1
Respirator? Diseases Drugs Glodal Market Report
???8
Including AYti-AsthwatiÐs AYd COPD Drugs Cough
AYd Cold PreparatioYs
Covering Gla?oswithKliYe PlÐ, AstraZeYeÐa PlÐ,
MerÐk Co., Novartis AG, JohYsoY JohYsoY
Fed ???8
2

• Reasons to Purchase
• Outperform competitors using accurate up to date
  demand-side dynamics information.
• Identify growth segments for investment.
• Facilitate decision making on the basis of
  historic and forecast data and the drivers and
  restraints on the market.
• Create regional and country strategies on the
  basis of local data and analysis.
• Stay abreast of the latest customer and market
  research findings
• Benchmark performance against key competitors.
• Develop strategies based on likely future
  developments.
• Utilize the relationships between key data sets
  for superior strategizing.
• Suitable for supporting your internal and
  external presentations with reliable high quality
  data and analysis
• Gain a global perspective on the development of
  the market.
• Report will be updated with the latest data and
  delivered to you within 3-5 working days of
  order.
• Scope
• Markets Covered Anti-Asthmatics And COPD Drugs
  Cough And Cold Preparations
• Companies Mentioned GlaxosmithKline Plc,
  AstraZeneca Plc, Merck Co., Novartis AG,
  Johnson Johnson
• Countries Brazil, China, France, Germany, India,
  Italy, Japan, Spain, Russia, UK, USA and
  Australia.
• Regions Asia-Pacific, Western Europe, Eastern
  Europe, North America, South America, Middle East
  And Africa

3
Respiratory Diseases Drugs Market Characteristics

• Respiratory diseases drugs market covers drugs
  that are used in the treatment of a wide range of
  respiratory diseases such as asthma, chronic
  obstructive pulmonary disease (COPD), chronic and
  acute bronchitis, emphysema and cystic fibrosis.
  Some of the major drugs in the market include
  antimuscarinics, corticosteroids, Codral,
  Coldrex and Lemsip.
• The segments that are covered include
  Anti-Asthmatics And COPD Drugs Cough And Cold
  Preparations
• In this report market value is defined as the
  revenues organizations earn by selling their
  goods and services within the specified market,
  based on the price at which they sell. Only
  goods and services traded between entities are
  included.
• The revenues for a specified geography are
  consumption values that is, they are revenues
  generated by organizations in the specified
  geography within the specified market,
  irrespective of where they are produced.

4
Respiratory Diseases Drugs Market Historic Growth
The global respiratory diseases drugs market grew
from X billion in 2013 to X billion in 2017 at
a compound annual growth rate (CAGR) of X. The
chart and table below shows the year-on-year
growth of the global respiratory diseases drugs
market during 2013 2017.
Drivers of the Market Restraints on the Market
5
Respiratory Diseases Drugs Market Forecast Growth
The global respiratory diseases drugs market grew
from XX billion in 2017 to XX billion in 2021
at a compound annual growth rate (CAGR) of
XX. The chart and table below shows the
year-on-year growth of the global respiratory
diseases drugs market during 2017 - 2021.
Drivers of the Market Restraints on the Market
6
Respiratory Diseases Drugs Market Segmentation
The chart and table below shows the split of the
respiratory diseases drugs market in 2017.
The total market value for respiratory diseases
drugs was X billion in 2017. The markets that
are covered include Anti-Asthmatics And COPD
Drugs Cough And Cold Preparations. Anti-Asthmati
cs And COPD Drugs was the X largest
segment in the respiratory diseases drugs
market with X share of the market. The market
value for the Anti- asthmatics and COPD drugs was
X billion in 2017. Cough And Cold Preparations
made up around X share of the market. The market
value for the cough and cold preparations was X
billion in 2017.
7
Respiratory Diseases Drugs Market Regional And
Country Analysis
The Asia Pacific was the largest region in the
respiratory diseases drugs market in 2017,
respiratory diseases drugs for X billion or X
market share. North America was the x largest
region respiratory diseases drugs for X billion
or X market share. Western Europe was the x
largest region respiratory diseases drugs for X
billion or X market share.
8
Respiratory Diseases Drugs Market Competitive
Landscape
The leading competitors in the global
respiratory diseases drugs market are
GlaxosmithKline Plc, AstraZeneca Plc, Merck
Co., Novartis AG, Johnson Johnson. The
chart and table below displays the percentage
market share of the top players in the
respiratory diseases drugs market industry.
Company Profile GlaxosmithKline
Plc Overview Products and Services
Strategy Financial Performance
9
AstraZeneca Plc Overview Products and Services
Strategy Financial Performance Merck
Co. Overview Products and Services
Strategy Financial Performance Novartis
AG Overview Products and Services
Strategy Financial Performance Johnson
Johnson Overview Products and Services
Strategy Financial Performance